MA41790A - Dérivé de morphinane - Google Patents

Dérivé de morphinane

Info

Publication number: MA41790A
Authority: MA; Morocco
Prior art keywords: morphinane derivative; morphinane; derivative
Prior art date: 2015-03-17

Application number

MA041790A

Other languages

English (en)

Other versions

MA41790B1 (fr

Inventor

Hideaki Fujii

Kohei Hayashida

Masaaki Hirose

Hiroshi Nagase

Eriko Nakata

Isao Ooi

Akiyoshi Saitoh

Original Assignee

Nippon Chemiphar Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-03-17

Filing date

2016-03-17

Publication date

2021-06-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56919074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA41790(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-03-17 Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co

2021-06-02 Publication of MA41790A publication Critical patent/MA41790A/fr

2022-02-28 Publication of MA41790B1 publication Critical patent/MA41790B1/fr

Links

150000003809 morphinane derivatives Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

MA41790A 2015-03-17 2016-03-17 Dérivé de morphinane MA41790B1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2015054079		2015-03-17
PCT/JP2016/058475 WO2016148232A1 (fr)	2015-03-17	2016-03-17	Dérivé de morphinane

Publications (2)

Publication Number	Publication Date
MA41790A true MA41790A (fr)	2021-06-02
MA41790B1 MA41790B1 (fr)	2022-02-28

Family

ID=56919074

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA41790A MA41790B1 (fr)	2015-03-17	2016-03-17	Dérivé de morphinane

Country Status (23)

Country	Link
US (4)	US10442802B2 (fr)
EP (2)	EP3272750B1 (fr)
JP (5)	JP6692345B2 (fr)
KR (2)	KR102551969B1 (fr)
CN (3)	CN113292559B (fr)
AU (2)	AU2016234222C1 (fr)
BR (1)	BR112017019805B1 (fr)
CA (1)	CA2979023C (fr)
CY (1)	CY1124908T1 (fr)
DK (1)	DK3272750T3 (fr)
ES (1)	ES2904511T3 (fr)
HU (1)	HUE057266T2 (fr)
IL (1)	IL254473B (fr)
MA (1)	MA41790B1 (fr)
MX (2)	MX2021008741A (fr)
MY (1)	MY197742A (fr)
PH (1)	PH12017501655B1 (fr)
PL (1)	PL3272750T3 (fr)
RU (1)	RU2762567C2 (fr)
SG (2)	SG10201907667RA (fr)
TW (2)	TWI775723B (fr)
WO (1)	WO2016148232A1 (fr)
ZA (1)	ZA201706882B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN113292559B (zh) *	2015-03-17	2024-04-02	日本化学药品株式会社	吗啡喃衍生物
US20210371422A1 (en)	2016-08-09	2021-12-02	Nippon Chemiphar Co., Ltd.	Morphinan derivative
US11633392B2 (en) *	2016-09-16	2023-04-25	Nippon Chemiphar Co., Ltd.	Use of morphinan derivative for therapeutic treatment of opioid delta receptor agonist-related disease
JP7283711B2 (ja) *	2016-10-03	2023-05-30	学校法人星薬科大学	モルヒナン誘導体を含む医薬組成物及びその鎮痛剤への使用
US12202830B2 (en)	2019-07-19	2025-01-21	Nippon Chemiphar Co., Ltd.	Method for producing morphinan derivative
AU2020317503A1 (en)	2019-07-19	2022-02-10	Nippon Chemiphar Co., Ltd.	Method for producing phenol derivative
WO2022045301A1 (fr)	2020-08-28	2022-03-03	日本ケミファ株式会社	Procédé de préparation d'un dérivé de morphinane à chaîne principale formée d'éther diarylique utilisant un nouveau catalyseur au cuivre
CN116997360A (zh) *	2021-02-26	2023-11-03	学校法人东京理科大学	应激相关障碍的治疗或预防用医药组合物
CA3211977A1 (fr) *	2021-02-26	2022-09-01	Tokyo University Of Science Foundation	Composition pharmaceutique pour le traitement ou la prevention de troubles lies au stress
WO2025197843A1 (fr) *	2024-03-18	2025-09-25	学校法人東京理科大学	Composition pharmaceutique pour le traitement et la prévention de l'anhédonie

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2005231995A (ja)	1999-12-22	2005-09-02	Meiji Seika Kaisha Ltd	オピオイドδ受容体アゴニスト／アンタゴニストとして有用なスピロ化合物
DE10161963A1 (de) *	2001-12-17	2003-07-03	Johannes Schuetz	6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
CL2004000754A1 (es)	2003-04-11	2005-02-25	Janssen Pharmaceutica Nv	Uso de compuestos derivados de 4-fenil-4-(1h-imidazol-2-il)piperidina, como agonistas delta-opioides no peptidicos, para preparar un medicamento util en prevenir o tratar trastornos del sistema nervioso central.
EP1869045A1 (fr)	2005-04-04	2007-12-26	AstraZeneca AB	Nouveaux diazaspiroalcanes et leur application au traitement de maladies faisant intervenir ccr8
JPWO2008001859A1 (ja)	2006-06-30	2009-11-26	学校法人北里研究所	オピオイドδ受容体アゴニスト
CN101918403A (zh)	2007-09-06	2010-12-15	阵列生物制药公司	作为酪氨酸激酶抑制剂的吡唑并吡啶类化合物
JP5770197B2 (ja)	2009-10-30	2015-08-26	ヤンセンファーマシューティカエヌ．ベー．	デルタオピオイド受容体調節因子としてのピラジン
EP2525659B1 (fr)	2010-01-19	2019-02-27	Merck Sharp & Dohme Corp.	COMPOSÉS PYRAZOLO[1,5-a]PYRIMIDINES EN TANT QU'INHIBITEURS DE mTOR
US8987293B2 (en)	2010-12-23	2015-03-24	Phoenix Pharmalabs, Inc.	Morphinans useful as analgesics
JP2014073964A (ja)	2011-01-28	2014-04-24	Kitasato Institute	モルヒナン誘導体
JP6061857B2 (ja)	2011-09-09	2017-01-18	学校法人北里研究所	モルヒナン誘導体
WO2014021273A1 (fr)	2012-07-30	2014-02-06	学校法人北里研究所	Dérivés morphinane
ES2623262T3 (es)	2012-12-14	2017-07-10	Purdue Pharma Lp	Derivados de morfinano que contienen nitrógeno y el uso de los mismos
EP2966074B1 (fr) *	2013-03-08	2018-07-25	The Kitasato Institute	Dérivé de morphinane
CN113292559B (zh) *	2015-03-17	2024-04-02	日本化学药品株式会社	吗啡喃衍生物
US11633392B2 (en)	2016-09-16	2023-04-25	Nippon Chemiphar Co., Ltd.	Use of morphinan derivative for therapeutic treatment of opioid delta receptor agonist-related disease

2016
- 2016-03-17 CN CN202110578658.0A patent/CN113292559B/zh active Active
- 2016-03-17 KR KR1020177029778A patent/KR102551969B1/ko active Active
- 2016-03-17 MX MX2021008741A patent/MX2021008741A/es unknown
- 2016-03-17 RU RU2017134286A patent/RU2762567C2/ru active
- 2016-03-17 MY MYPI2017703345A patent/MY197742A/en unknown
- 2016-03-17 PL PL16765061T patent/PL3272750T3/pl unknown
- 2016-03-17 EP EP16765061.3A patent/EP3272750B1/fr active Active
- 2016-03-17 KR KR1020237022162A patent/KR102813010B1/ko active Active
- 2016-03-17 TW TW105108248A patent/TWI775723B/zh active
- 2016-03-17 SG SG10201907667RA patent/SG10201907667RA/en unknown
- 2016-03-17 MX MX2017011824A patent/MX384744B/es unknown
- 2016-03-17 CA CA2979023A patent/CA2979023C/fr active Active
- 2016-03-17 JP JP2017506606A patent/JP6692345B2/ja active Active
- 2016-03-17 CN CN202110577382.4A patent/CN113292558A/zh active Pending
- 2016-03-17 WO PCT/JP2016/058475 patent/WO2016148232A1/fr not_active Ceased
- 2016-03-17 CN CN201680016083.0A patent/CN107614500B/zh active Active
- 2016-03-17 EP EP21203556.2A patent/EP3974430A1/fr active Pending
- 2016-03-17 DK DK16765061.3T patent/DK3272750T3/da active
- 2016-03-17 MA MA41790A patent/MA41790B1/fr unknown
- 2016-03-17 BR BR112017019805-3A patent/BR112017019805B1/pt active IP Right Grant
- 2016-03-17 AU AU2016234222A patent/AU2016234222C1/en active Active
- 2016-03-17 TW TW111126713A patent/TWI778933B/zh active
- 2016-03-17 US US15/558,026 patent/US10442802B2/en active Active
- 2016-03-17 SG SG11201707427TA patent/SG11201707427TA/en unknown
- 2016-03-17 ES ES16765061T patent/ES2904511T3/es active Active
- 2016-03-17 HU HUE16765061A patent/HUE057266T2/hu unknown
2017
- 2017-09-11 PH PH12017501655A patent/PH12017501655B1/en unknown
- 2017-09-13 IL IL254473A patent/IL254473B/en unknown
- 2017-10-11 ZA ZA2017/06882A patent/ZA201706882B/en unknown
2019
- 2019-07-19 US US16/517,081 patent/US10995092B2/en active Active
2020
- 2020-04-10 JP JP2020071041A patent/JP2020117533A/ja not_active Ceased
- 2020-10-13 US US17/069,589 patent/US11643411B2/en active Active
- 2020-11-18 AU AU2020270503A patent/AU2020270503C9/en active Active
2022
- 2022-01-18 CY CY20221100041T patent/CY1124908T1/el unknown
- 2022-03-18 JP JP2022044083A patent/JP7375076B2/ja active Active
2023
- 2023-01-09 US US18/094,687 patent/US20230159530A1/en active Pending
- 2023-10-25 JP JP2023183221A patent/JP2024010098A/ja active Pending
2025
- 2025-06-10 JP JP2025096247A patent/JP2025131782A/ja active Pending

Also Published As

Publication number	Publication date
JP7375076B2 (ja)	2023-11-07
CA2979023A1 (fr)	2016-09-22
MX2021008741A (es)	2022-11-01
US20230159530A1 (en)	2023-05-25
KR20230104767A (ko)	2023-07-10
RU2762567C2 (ru)	2021-12-21
AU2020270503A1 (en)	2020-12-17
EP3272750A4 (fr)	2018-08-08
JP6692345B2 (ja)	2020-05-13
IL254473B (en)	2022-05-01
CN107614500A (zh)	2018-01-19
US10995092B2 (en)	2021-05-04
TWI775723B (zh)	2022-09-01
PH12017501655A1 (en)	2018-03-12
JPWO2016148232A1 (ja)	2018-03-08
AU2020270503C9 (en)	2024-02-29
EP3272750B1 (fr)	2021-11-03
SG10201907667RA (en)	2019-09-27
WO2016148232A1 (fr)	2016-09-22
CN113292559B (zh)	2024-04-02
PL3272750T3 (pl)	2022-03-07
RU2017134286A3 (fr)	2019-04-19
HUE057266T2 (hu)	2022-05-28
AU2016234222C1 (en)	2021-02-11
US11643411B2 (en)	2023-05-09
SG11201707427TA (en)	2017-10-30
US20210040094A1 (en)	2021-02-11
BR112017019805A2 (pt)	2018-05-29
BR112017019805B1 (pt)	2023-01-31
NZ735939A (en)	2024-09-27
MX384744B (es)	2025-03-14
AU2016234222B2 (en)	2020-08-27
CN113292558A (zh)	2021-08-24
US10442802B2 (en)	2019-10-15
KR102813010B1 (ko)	2025-05-26
ZA201706882B (en)	2022-02-23
TW202244044A (zh)	2022-11-16
US20180057493A1 (en)	2018-03-01
KR102551969B1 (ko)	2023-07-05
AU2016234222A1 (en)	2017-10-26
ES2904511T3 (es)	2022-04-05
PH12017501655B1 (en)	2022-07-22
MX2017011824A (es)	2018-04-20
JP2024010098A (ja)	2024-01-23
MA41790B1 (fr)	2022-02-28
HK1249900A1 (en)	2018-11-16
KR20180002616A (ko)	2018-01-08
EP3974430A1 (fr)	2022-03-30
IL254473A0 (en)	2017-11-30
AU2020270503C1 (en)	2023-08-10
CN107614500B (zh)	2021-06-15
JP2025131782A (ja)	2025-09-09
EP3272750A1 (fr)	2018-01-24
RU2017134286A (ru)	2019-04-05
CN113292559A (zh)	2021-08-24
JP2020117533A (ja)	2020-08-06
US20200079775A1 (en)	2020-03-12
DK3272750T3 (en)	2022-01-03
JP2022081656A (ja)	2022-05-31
AU2020270503B9 (en)	2023-10-12
CA2979023C (fr)	2023-09-26
CY1124908T1 (el)	2023-01-05
TW201638089A (zh)	2016-11-01
AU2020270503B2 (en)	2023-02-02
TWI778933B (zh)	2022-09-21
MY197742A (en)	2023-07-12

Publication	Publication Date	Title
DK3319956T3 (da)	2021-03-29	Substituerede oxopyridinderivater
DK3283625T3 (da)	2020-03-02	Nukleasemedieret genomeditering
PT3157915T (pt)	2019-05-16	Compostos de dihidroisoquinolinona substituídos
DK3277719T3 (da)	2022-05-02	Polypeptider
DK3305788T3 (da)	2020-09-28	Janus-kinase-hæmmer
PT3298027T (pt)	2022-01-26	Compostos depsipéptidos antelmínticos
EP3219592C0 (fr)	2024-08-21	Fixation
LT3402792T (lt)	2021-12-10	Chinolin-2-ono dariniai
MA41790A (fr)	2021-06-02	Dérivé de morphinane
LT3457851T (lt)	2021-10-11	Sobetiromo dariniai
DK3270930T3 (da)	2021-10-04	Præeklampsi
LT3371168T (lt)	2020-10-12	Indolin-2-ono dariniai
EP3309163A4 (fr)	2019-01-09	Dérivé de dihydropyrrolopyrazole substitué
CL2016002165A1 (es)	2017-06-09	Compuestos de aminocarbonilcarbamato
PT3131898T (pt)	2020-06-17	Derivados de fluoroalquilfluoreno
LT3362444T (lt)	2021-06-25	Junginiai
LT3256486T (lt)	2020-06-25	Grifitzino mutantai
DK3597189T3 (da)	2022-06-27	Krystallinske forbindelser
DK3292136T3 (da)	2021-03-22	Penicillin-g-acylaser
EP2966074A4 (fr)	2016-09-14	Dérivé de morphinane
DK3274482T3 (da)	2020-01-06	Stenborsknop
DE112015006486A5 (de)	2018-01-04	Inkubationsrinne
EP3444345C0 (fr)	2024-07-10	Dérivé d'arnmicro-143
EP3372589A4 (fr)	2019-04-24	Dérivé pyrimidine
EP3346592A4 (fr)	2019-04-24	Machine tournante